Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers.

Harrison SA, Calanna S, Cusi K, Linder M, Okanoue T, Ratziu V, Sanyal A, Sejling AS, Newsome PN. Contemp Clin Trials. 2020 Oct 8:106174. doi: 10.1016/j.cct.2020.106174.

in cat NOT

Stay Connected

Would you like to receive updates from ProSciento?